» Articles » PMID: 39015554

Neutrophil Extracellular Traps in Cancer

Overview
Journal MedComm (2020)
Specialty Health Services
Date 2024 Jul 17
PMID 39015554
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophil extracellular traps (NETs), which consist of chromatin DNA studded with granule proteins, are released by neutrophils in response to both infectious and sterile inflammation. Beyond the canonical role in defense against pathogens, the extrusion of NETs also contributes to the initiation, metastasis, and therapeutic response of malignant diseases. Recently, NETs have been implicated in the development and therapeutic responses of various types of tumors. Although extensive work regarding inflammation in tumors has been reported, a comprehensive summary of how these web-like extracellular structures initiate and propagate tumor progression under the specific microenvironment is lacking. In this review, we demonstrate the initiators and related signaling pathways that trigger NETs formation in cancers. Additionally, this review will outline the current molecular mechanisms and regulatory networks of NETs during dormant cancer cells awakening, circulating tumor cells (CTCs) extravasation, and metastatic recurrence of cancer. This is followed by a perspective on the current and potential clinical potential of NETs as therapeutic targets in the treatment of both local and metastatic disease, including the improvement of the efficacy of existing therapies.

Citing Articles

The emerging role of neutrophil extracellular traps in autoimmune and autoinflammatory diseases.

Zeng L, Xiang W, Xiao W, Wu Y, Sun L MedComm (2020). 2025; 6(3):e70101.

PMID: 40060194 PMC: 11885892. DOI: 10.1002/mco2.70101.


Association between systemic immune-inflammation index and the risk of all-cause, cancer and non-cancer mortality in the general population: results from national health and nutrition examination survey 2005-2018.

Wu S, Liu Z, Li X, Gao S, Xia P BMC Public Health. 2025; 25(1):227.

PMID: 39833806 PMC: 11744828. DOI: 10.1186/s12889-025-21423-1.


Pyrrolopyrazine Compounds as ERK5 Inhibitors for Treating Cancer.

Sabnis R ACS Med Chem Lett. 2025; 16(1):16-17.

PMID: 39811115 PMC: 11726354. DOI: 10.1021/acsmedchemlett.4c00580.


Neutrophil Extracellular Trap Formation Model Induced by Monosodium Urate and Phorbol Myristate Acetate: Involvement in MAPK Signaling Pathways.

Wu C, Xu X, Shi Y, Li F, Zhang X, Huang Y Int J Mol Sci. 2025; 26(1.

PMID: 39796001 PMC: 11719704. DOI: 10.3390/ijms26010143.


Neutrophil Extracellular Traps Induce Brain Edema Around Intracerebral Hematoma via ERK-Mediated Regulation of MMP9 and AQP4.

Tang J, Yue J, Tao Y, Zhao G, Yi X, Zhang M Transl Stroke Res. 2024; .

PMID: 39733198 DOI: 10.1007/s12975-024-01318-w.

References
1.
Czeiger D, Shaked G, Eini H, Vered I, Belochitski O, Avriel A . Measurement of circulating cell-free DNA levels by a new simple fluorescent test in patients with primary colorectal cancer. Am J Clin Pathol. 2011; 135(2):264-70. DOI: 10.1309/AJCP4RK2IHVKTTZV. View

2.
Xie M, Hao Y, Feng L, Wang T, Yao M, Li H . Neutrophil Heterogeneity and its Roles in the Inflammatory Network after Ischemic Stroke. Curr Neuropharmacol. 2022; 21(3):621-650. PMC: 10207908. DOI: 10.2174/1570159X20666220706115957. View

3.
Giancotti F . Mechanisms governing metastatic dormancy and reactivation. Cell. 2013; 155(4):750-64. PMC: 4354734. DOI: 10.1016/j.cell.2013.10.029. View

4.
Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View

5.
Zhang Y, Hu Y, Ma C, Sun H, Wei X, Li M . Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutrophil Extracellular Traps in Patients With Gastric Adenocarcinoma. Front Oncol. 2020; 10:1036. PMC: 7344202. DOI: 10.3389/fonc.2020.01036. View